Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 121

1.

Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient.

Castellazzi M, Morotti A, Tamborino C, Alessi F, Pilotto S, Baldi E, Caniatti LM, Trentini A, Casetta I, Granieri E, Pugliatti M, Fainardi E, Bellini T.

Fluids Barriers CNS. 2020 Feb 5;17(1):14. doi: 10.1186/s12987-020-0173-2.

2.

Specific antibodies reacting to JC polyomavirus capsid protein mimotopes in sera from multiple sclerosis and other neurological diseases-affected patients.

Mazzoni E, Bononi I, Pietrobon S, Torreggiani E, Rossini M, Pugliatti M, Casetta I, Castellazzi M, Granieri E, Guerra G, Martini F, Tognon M.

J Cell Physiol. 2020 Feb 3. doi: 10.1002/jcp.29533. [Epub ahead of print]

PMID:
32012272
3.

Migration - a route to multiple sclerosis risk globalization?

Pugliatti M, Ferri C.

Nat Rev Neurol. 2020 Feb;16(2):67-68. doi: 10.1038/s41582-019-0308-8. No abstract available.

PMID:
31907418
4.

Autophagy and mitophagy biomarkers are reduced in sera of patients with Alzheimer's disease and mild cognitive impairment.

Castellazzi M, Patergnani S, Donadio M, Giorgi C, Bonora M, Bosi C, Brombo G, Pugliatti M, Seripa D, Zuliani G, Pinton P.

Sci Rep. 2019 Dec 27;9(1):20009. doi: 10.1038/s41598-019-56614-5.

5.

Increased Levels of Endothelin-1 in Cerebrospinal Fluid Are a Marker of Poor Visual Recovery after Optic Neuritis in Multiple Sclerosis Patients.

Castellazzi M, Lamberti G, Resi MV, Baldi E, Caniatti LM, Galante G, Perri P, Pugliatti M.

Dis Markers. 2019 Sep 10;2019:9320791. doi: 10.1155/2019/9320791. eCollection 2019.

6.

Correlation between auto/mitophagic processes and magnetic resonance imaging activity in multiple sclerosis patients.

Castellazzi M, Patergnani S, Donadio M, Giorgi C, Bonora M, Fainardi E, Casetta I, Granieri E, Pugliatti M, Pinton P.

J Neuroinflammation. 2019 Jun 27;16(1):131. doi: 10.1186/s12974-019-1526-0.

7.

Changes in the sex ratio are a good indicator of changes in MS incidence - Commentary.

Pugliatti M.

Mult Scler. 2019 Oct;25(12):1570-1571. doi: 10.1177/1352458519845114. Epub 2019 May 15. No abstract available.

PMID:
31088339
8.

Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study.

Leurs CE, Twaalfhoven H, Lissenberg-Witte BI, van Pesch V, Dujmovic I, Drulovic J, Castellazzi M, Bellini T, Pugliatti M, Kuhle J, Villar LM, Alvarez-Cermeño JC, Alvarez-Lafuente R, Hegen H, Deisenhammer F, Walchhofer LM, Thouvenot E, Comabella M, Montalban X, Vécsei L, Rajda C, Galimberti D, Scarpini E, Altintas A, Rejdak K, Frederiksen JL, Pihl-Jensen G, Jensen P, Khalil M, Voortman MM, Fazekas F, Saiz A, La Puma D, Vercammen M, Vanopdenbosch L, Uitdehaag B, Killestein J, Bridel C, Teunissen C.

Mult Scler. 2019 May 8:1352458519845844. doi: 10.1177/1352458519845844. [Epub ahead of print]

PMID:
31066634
9.

Multiplex Matrix Metalloproteinases Analysis in the Cerebrospinal Fluid Reveals Potential Specific Patterns in Multiple Sclerosis Patients.

Castellazzi M, Ligi D, Contaldi E, Quartana D, Fonderico M, Borgatti L, Bellini T, Trentini A, Granieri E, Fainardi E, Mannello F, Pugliatti M.

Front Neurol. 2018 Dec 18;9:1080. doi: 10.3389/fneur.2018.01080. eCollection 2018.

10.

Incidence study of Guillain-Barré syndrome in the province of Ferrara, Northern Italy, between 2003 and 2017. A 40-year follow-up.

Granieri E, Andreasi NG, De Martin P, Govoni V, Castellazzi M, Cesnik E, Pugliatti M, Casetta I.

Neurol Sci. 2019 Mar;40(3):603-609. doi: 10.1007/s10072-018-3688-4. Epub 2019 Jan 7.

PMID:
30617450
11.

Shedding light on the link between early life sun exposure and risk of multiple sclerosis: results from the EnvIMS Study.

Magalhaes S, Pugliatti M, Riise T, Myhr KM, Ciampi A, Bjornevik K, Wolfson C.

Int J Epidemiol. 2019 Aug 1;48(4):1073-1082. doi: 10.1093/ije/dyy269.

PMID:
30561654
12.

Multiple sclerosis registries in Europe - An updated mapping survey.

Glaser A, Stahmann A, Meissner T, Flachenecker P, Horáková D, Zaratin P, Brichetto G, Pugliatti M, Rienhoff O, Vukusic S, de Giacomoni AC, Battaglia MA, Brola W, Butzkueven H, Casey R, Drulovic J, Eichstädt K, Hellwig K, Iaffaldano P, Ioannidou E, Kuhle J, Lycke K, Magyari M, Malbaša T, Middleton R, Myhr KM, Notas K, Orologas A, Otero-Romero S, Pekmezovic T, Sastre-Garriga J, Seeldrayers P, Soilu-Hänninen M, Stawiarz L, Trojano M, Ziemssen T, Hillert J, Thalheim C.

Mult Scler Relat Disord. 2019 Jan;27:171-178. doi: 10.1016/j.msard.2018.09.032. Epub 2018 Oct 4. No abstract available.

PMID:
30384204
13.

Multiple Sclerosis in Italy: A 40-Year Follow-Up of the Prevalence in Ferrara.

Granieri E, De Mattia G, Laudisi M, Govoni V, Castellazzi M, Caniatti L, Baldi E, Groppo E, Pugliatti M, Casetta I.

Neuroepidemiology. 2018;51(3-4):158-165. doi: 10.1159/000491548. Epub 2018 Aug 21.

PMID:
30130759
14.

A framework for measurement and harmonization of pediatric multiple sclerosis etiologic research studies: The Pediatric MS Tool-Kit.

Magalhaes S, Banwell B, Bar-Or A, Fortier I, Hanwell HE, Lim M, Matt GE, Neuteboom RF, O'Riordan DL, Schneider PK, Pugliatti M, Shatenstein B, Tansey CM, Wassmer E, Wolfson C.

Mult Scler. 2019 Jul;25(8):1170-1177. doi: 10.1177/1352458518783345. Epub 2018 Jun 22.

15.

Multiple sclerosis in the Republic of San Marino, Italian peninsula: an incidence and prevalence study from a high-risk area.

Caniglia-Tenaglia M, Guttmann S, Monaldini C, Manzaroli D, Volpini M, Stumpo M, Groppo E, Casetta I, Govoni V, Fonderico M, Pugliatti M, Granieri E.

Neurol Sci. 2018 Jul;39(7):1231-1236. doi: 10.1007/s10072-018-3402-6. Epub 2018 Apr 18.

PMID:
29671168
16.

Autophagy and mitophagy elements are increased in body fluids of multiple sclerosis-affected individuals.

Patergnani S, Castellazzi M, Bonora M, Marchi S, Casetta I, Pugliatti M, Giorgi C, Granieri E, Pinton P.

J Neurol Neurosurg Psychiatry. 2018 Apr;89(4):439-441. doi: 10.1136/jnnp-2017-316234. Epub 2017 Sep 2. No abstract available.

PMID:
28866627
17.

Epidemiological Study of Huntington's Disease in the Province of Ferrara, Italy.

Carrassi E, Pugliatti M, Govoni V, Sensi M, Casetta I, Granieri E.

Neuroepidemiology. 2017;49(1-2):18-23. doi: 10.1159/000479697. Epub 2017 Aug 12.

PMID:
28803251
18.

Evaluation of total, ceruloplasmin-associated and type II ferroxidase activities in serum and cerebrospinal fluid of multiple sclerosis patients.

Trentini A, Castellazzi M, Romani A, Squerzanti M, Baldi E, Caniatti ML, Pugliatti M, Granieri E, Fainardi E, Bellini T, Cervellati C.

J Neurol Sci. 2017 Jun 15;377:133-136. doi: 10.1016/j.jns.2017.04.021. Epub 2017 Apr 13.

PMID:
28477683
19.

Physical activity is associated with a decreased multiple sclerosis risk: The EnvIMS study.

Wesnes K, Myhr KM, Riise T, Cortese M, Pugliatti M, Boström I, Landtblom AM, Wolfson C, Bjørnevik K.

Mult Scler. 2018 Feb;24(2):150-157. doi: 10.1177/1352458517694088. Epub 2017 Feb 1.

PMID:
28273774
20.

Negative interaction between smoking and EBV in the risk of multiple sclerosis: The EnvIMS study.

Bjørnevik K, Riise T, Bostrom I, Casetta I, Cortese M, Granieri E, Holmøy T, Kampman MT, Landtblom AM, Magalhaes S, Pugliatti M, Wolfson C, Myhr KM.

Mult Scler. 2017 Jun;23(7):1018-1024. doi: 10.1177/1352458516671028. Epub 2016 Sep 23.

PMID:
27663872
21.

People with MS should consume a low-salt diet - Commentary.

Pugliatti M.

Mult Scler. 2016 Dec;22(14):1781-1782. Epub 2016 Sep 8. No abstract available.

PMID:
27609132
22.

Environmental and genetic factors in pediatric inflammatory demyelinating diseases.

Waubant E, Ponsonby AL, Pugliatti M, Hanwell H, Mowry EM, Hintzen RQ.

Neurology. 2016 Aug 30;87(9 Suppl 2):S20-7. doi: 10.1212/WNL.0000000000003029. Review.

PMID:
27572857
23.

Definition and diagnostic criteria of sleep-related hypermotor epilepsy.

Tinuper P, Bisulli F, Cross JH, Hesdorffer D, Kahane P, Nobili L, Provini F, Scheffer IE, Tassi L, Vignatelli L, Bassetti C, Cirignotta F, Derry C, Gambardella A, Guerrini R, Halasz P, Licchetta L, Mahowald M, Manni R, Marini C, Mostacci B, Naldi I, Parrino L, Picard F, Pugliatti M, Ryvlin P, Vigevano F, Zucconi M, Berkovic S, Ottman R.

Neurology. 2016 May 10;86(19):1834-42. doi: 10.1212/WNL.0000000000002666. Epub 2016 Apr 15. Review.

24.

TBK1 is associated with ALS and ALS-FTD in Sardinian patients.

Borghero G, Pugliatti M, Marrosu F, Marrosu MG, Murru MR, Floris G, Cannas A, Occhineri P, Cau TB, Loi D, Ticca A, Traccis S, Manera U, Canosa A, Moglia C, Calvo A, Barberis M, Brunetti M, Gibbs JR, Renton AE, Errichiello E, Zoledziewska M, Mulas A, Qian Y, Din J, Pliner HA, Traynor BJ, Chiò A; ITALSGEN and SARDINALS Consortia.

Neurobiol Aging. 2016 Jul;43:180.e1-5. doi: 10.1016/j.neurobiolaging.2016.03.028. Epub 2016 Apr 9.

PMID:
27156075
25.

Prevalence of Multiple Sclerosis in the Republic of Moldova.

Marcoci C, Lisnic V, Gavriliuc M, Odainic O, Sangheli M, Belenciuc A, Leone MA, Casetta I, Pugliatti M.

Neuroepidemiology. 2016;46(3):166-72. doi: 10.1159/000443931. Epub 2016 Feb 6.

PMID:
26849377
26.

Does low socioeconomic status in early life protect against multiple sclerosis? A multinational, case-control study.

Goulden R, Riise T, Myhr KM, Pugliatti M, Wolfson C.

Eur J Neurol. 2016 Jan;23(1):168-74. doi: 10.1111/ene.12830. Epub 2015 Oct 16.

PMID:
26475404
27.

The burden of multiple sclerosis variants in continental Italians and Sardinians.

Barizzone N, Zara I, Sorosina M, Lupoli S, Porcu E, Pitzalis M, Zoledziewska M, Esposito F, Leone M, Mulas A, Cocco E, Ferrigno P, Guerini FR, Brambilla P, Farina G, Murru R, Deidda F, Sanna S, Loi A, Barlassina C, Vecchio D, Zauli A, Clarelli F, Braga D, Poddie F, Cantello R, Martinelli V, Comi G, Frau J, Lorefice L, Pugliatti M, Rosati G; PROGEMUS (PROgnostic GEnetic factors in MUltiple Sclerosis) Consortium PROGRESSO (Italian network of Primary Progressive Multiple Sclerosis) Consortium, Melis M, Marrosu MG, Cusi D, Cucca F, Martinelli Boneschi F, Sanna S, D'Alfonso S.

Mult Scler. 2015 Oct;21(11):1385-95. doi: 10.1177/1352458515596599.

PMID:
26438306
28.

An overview of pregnancy-related issues in patients with multiple sclerosis.

Pozzilli C, Pugliatti M; ParadigMS Group.

Eur J Neurol. 2015 Oct;22 Suppl 2:34-9. doi: 10.1111/ene.12797. Review.

PMID:
26374512
29.

A Multicentric Prospective Incidence Study of Guillain-Barré Syndrome in Italy. The ITANG Study.

Benedetti MD, Pugliatti M, D'Alessandro R, Beghi E, Chiò A, Logroscino G, Filippini G, Galeotti F, Massari M, Santuccio C, Raschetti R; ITANG Study Group.

Neuroepidemiology. 2015;45(2):90-9. doi: 10.1159/000438752. Epub 2015 Aug 29.

30.

ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry.

Borghero G, Pugliatti M, Marrosu F, Marrosu MG, Murru MR, Floris G, Cannas A, Parish LD, Cau TB, Loi D, Ticca A, Traccis S, Manera U, Canosa A, Moglia C, Calvo A, Barberis M, Brunetti M, Renton AE, Nalls MA, Traynor BJ, Restagno G, Chiò A; ITALSGEN and SARDINALS consortia.

Neurobiol Aging. 2015 Oct;36(10):2906.e1-5. doi: 10.1016/j.neurobiolaging.2015.06.013. Epub 2015 Jun 25.

31.

Natalizumab modulates the humoral response against HERV-Wenv73-88 in a follow-up study of Multiple Sclerosis patients.

Arru G, Caggiu E, Leoni S, Mameli G, Pugliatti M, Sechi GP, Sechi LA.

J Neurol Sci. 2015 Oct 15;357(1-2):106-8. doi: 10.1016/j.jns.2015.07.007. Epub 2015 Jul 8.

PMID:
26190523
32.

Personality traits predict perceived health-related quality of life in persons with multiple sclerosis.

Zarbo IR, Minacapelli E, Falautano M, Demontis S, Carpentras G, Pugliatti M.

Mult Scler. 2016 Apr;22(4):551-8. doi: 10.1177/1352458515594045. Epub 2015 Jul 10.

PMID:
26163067
33.

Patient expression of emotions and neurologist responses in first multiple sclerosis consultations.

Del Piccolo L, Pietrolongo E, Radice D, Tortorella C, Confalonieri P, Pugliatti M, Lugaresi A, Giordano A, Heesen C, Solari A; AutoMS Project.

PLoS One. 2015 Jun 1;10(6):e0127734. doi: 10.1371/journal.pone.0127734. eCollection 2015.

34.

Level of education and multiple sclerosis risk after adjustment for known risk factors: The EnvIMS study.

Bjørnevik K, Riise T, Cortese M, Holmøy T, Kampman MT, Magalhaes S, Myhr KM, Wolfson C, Pugliatti M.

Mult Scler. 2016 Jan;22(1):104-11. doi: 10.1177/1352458515579444. Epub 2015 May 26.

35.

The EnvIMS Study: Design and Methodology of an International Case-Control Study of Environmental Risk Factors in Multiple Sclerosis.

Magalhaes S, Pugliatti M, Casetta I, Drulovic J, Granieri E, Holmøy T, Kampman MT, Landtblom AM, Lauer K, Myhr KM, Parpinel M, Pekmezovic T, Riise T, Wolfson D, Zhu B, Wolfson C.

Neuroepidemiology. 2015;44(3):173-81. doi: 10.1159/000381779. Epub 2015 May 7.

36.

Timing of use of cod liver oil, a vitamin D source, and multiple sclerosis risk: The EnvIMS study.

Cortese M, Riise T, Bjørnevik K, Holmøy T, Kampman MT, Magalhaes S, Pugliatti M, Wolfson C, Myhr KM.

Mult Scler. 2015 Dec;21(14):1856-64. doi: 10.1177/1352458515578770. Epub 2015 May 6.

37.

Reduced duration of breastfeeding is associated with a higher risk of multiple sclerosis in both Italian and Norwegian adult males: the EnvIMS study.

Ragnedda G, Leoni S, Parpinel M, Casetta I, Riise T, Myhr KM, Wolfson C, Pugliatti M.

J Neurol. 2015 May;262(5):1271-7. doi: 10.1007/s00415-015-7704-9. Epub 2015 Mar 21.

PMID:
25794863
38.

Body size and the risk of multiple sclerosis in Norway and Italy: the EnvIMS study.

Wesnes K, Riise T, Casetta I, Drulovic J, Granieri E, Holmøy T, Kampman MT, Landtblom AM, Lauer K, Lossius A, Magalhaes S, Pekmezovic T, Bjørnevik K, Wolfson C, Pugliatti M, Myhr KM.

Mult Scler. 2015 Apr;21(4):388-95. doi: 10.1177/1352458514546785. Epub 2014 Sep 2.

PMID:
25182290
39.

Genetic architecture of ALS in Sardinia.

Borghero G, Pugliatti M, Marrosu F, Marrosu MG, Murru MR, Floris G, Cannas A, Parish LD, Occhineri P, Cau TB, Loi D, Ticca A, Traccis S, Manera U, Canosa A, Moglia C, Calvo A, Barberis M, Brunetti M, Pliner HA, Renton AE, Nalls MA, Traynor BJ, Restagno G, Chiò A; ITALSGEN and SARDINALS Consortia.

Neurobiol Aging. 2014 Dec;35(12):2882.e7-2882.e12. doi: 10.1016/j.neurobiolaging.2014.07.012. Epub 2014 Jul 18.

40.

Multiple sclerosis registries in Europe - results of a systematic survey.

Flachenecker P, Buckow K, Pugliatti M, Kes VB, Battaglia MA, Boyko A, Confavreux C, Ellenberger D, Eskic D, Ford D, Friede T, Fuge J, Glaser A, Hillert J, Holloway E, Ioannidou E, Kappos L, Kasilingam E, Koch-Henriksen N, Kuhle J, Lepore V, Middleton R, Myhr KM, Orologas A, Otero S, Pitschnau-Michel D, Rienhoff O, Sastre-Garriga J, Schyns-Liharska T, Sutovic D, Thalheim C, Trojano M, Vlasov YV, Yaldizli O; EUReMS Consortium.

Mult Scler. 2014 Oct;20(11):1523-32. doi: 10.1177/1352458514528760. Epub 2014 Apr 28.

PMID:
24777278
41.

Novel SPAST deletion and reduced DPY30 expression in a Spastic Paraplegia type 4 kindred.

Racis L, Storti E, Pugliatti M, Agnetti V, Tessa A, Santorelli FM.

BMC Med Genet. 2014 Apr 1;15:39. doi: 10.1186/1471-2350-15-39.

42.

Sun exposure and multiple sclerosis risk in Norway and Italy: The EnvIMS study.

Bjørnevik K, Riise T, Casetta I, Drulovic J, Granieri E, Holmøy T, Kampman MT, Landtblom AM, Lauer K, Lossius A, Magalhaes S, Myhr KM, Pekmezovic T, Wesnes K, Wolfson C, Pugliatti M.

Mult Scler. 2014 Jul;20(8):1042-9. doi: 10.1177/1352458513513968. Epub 2014 Jan 10.

PMID:
24414538
43.

Infantile-onset ascending hereditary spastic paralysis: a case report and brief literature review.

Racis L, Tessa A, Pugliatti M, Storti E, Agnetti V, Santorelli FM.

Eur J Paediatr Neurol. 2014 Mar;18(2):235-9. doi: 10.1016/j.ejpn.2013.09.009. Epub 2013 Oct 9. Review.

PMID:
24144828
44.

The high prevalence of hereditary spastic paraplegia in Sardinia, insular Italy.

Racis L, Tessa A, Di Fabio R, Storti E, Agnetti V, Casali C, Santorelli FM, Pugliatti M.

J Neurol. 2014 Jan;261(1):52-9. doi: 10.1007/s00415-013-7151-4. Epub 2013 Oct 20.

PMID:
24141732
45.

Season of infectious mononucleosis and risk of multiple sclerosis at different latitudes; the EnvIMS Study.

Lossius A, Riise T, Pugliatti M, Bjørnevik K, Casetta I, Drulovic J, Granieri E, Kampman MT, Landtblom AM, Lauer K, Magalhaes S, Myhr KM, Pekmezovic T, Wesnes K, Wolfson C, Holmøy T.

Mult Scler. 2014 May;20(6):669-74. doi: 10.1177/1352458513505693. Epub 2013 Sep 26.

PMID:
24072723
46.

Natalizumab inhibits the expression of human endogenous retroviruses of the W family in multiple sclerosis patients: a longitudinal cohort study.

Arru G, Leoni S, Pugliatti M, Mei A, Serra C, Delogu LG, Manetti R, Dolei A, Sotgiu S, Mameli G.

Mult Scler. 2014 Feb;20(2):174-82. doi: 10.1177/1352458513494957. Epub 2013 Jul 22.

PMID:
23877972
47.

Role Preferences of People with Multiple Sclerosis: Image-Revised, Computerized Self-Administered Version of the Control Preference Scale.

Solari A, Giordano A, Kasper J, Drulovic J, van Nunen A, Vahter L, Viala F, Pietrolongo E, Pugliatti M, Antozzi C, Radice D, Köpke S, Heesen C; AutoMS project.

PLoS One. 2013 Jun 18;8(6):e66127. doi: 10.1371/journal.pone.0066127. Print 2013.

48.

Decision-making in multiple sclerosis consultations in Italy: third observer and patient assessments.

Pietrolongo E, Giordano A, Kleinefeld M, Confalonieri P, Lugaresi A, Tortorella C, Pugliatti M, Radice D, Goss C, Heesen C, Solari A; AutoMS group.

PLoS One. 2013;8(4):e60721. doi: 10.1371/journal.pone.0060721. Epub 2013 Apr 2.

49.

Risk of Guillain-Barré syndrome after 2010-2011 influenza vaccination.

Galeotti F, Massari M, D'Alessandro R, Beghi E, Chiò A, Logroscino G, Filippini G, Benedetti MD, Pugliatti M, Santuccio C, Raschetti R; ITANG study group.

Eur J Epidemiol. 2013 May;28(5):433-44. doi: 10.1007/s10654-013-9797-8. Epub 2013 Mar 31.

50.

Multiple sclerosis: preventing progression and disability in MS-when to treat?

Pugliatti M.

Nat Rev Neurol. 2013 Mar;9(3):129-30. doi: 10.1038/nrneurol.2013.28. Epub 2013 Feb 19.

PMID:
23419371

Supplemental Content

Loading ...
Support Center